Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Joshua Rosenblat
The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease
Yale University
Psilocybin as a Treatment for Chronic Pain in Smokers
Yale University
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Centre for Addiction and Mental Health
Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement
University of California, San Diego
MDMA-Assisted Massed Exposure Therapy for PTSD
Emory University
Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)
Centre Hospitalier St Anne
MDMA Therapy in Veterans With PTSD
Sunstone Medical
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms
Centre Hospitalier Universitaire de Nīmes
Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder
Lakshmi N Yatham
Psilocybin-Assisted Therapy
Emory University
A Study of Psychedelics in Healthy Older Adults With Low Well-being
Jennifer Mitchell
Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD
Sunstone Medical
MDMA Assisted Therapy for BN
Icahn School of Medicine at Mount Sinai
Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.
Francisco A Moreno
MDMA-Assisted Therapy for Veterans With PTSD and Alcohol Use Disorder
VA Office of Research and Development
Subjective Experience Following Psilocybin
University of Calgary
Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients
Hospital Italiano de Buenos Aires
InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpression
Sunnybrook Health Sciences Centre
Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder
University of New Mexico
Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
Massachusetts General Hospital
Ketamine and Propofol NeuroImaging
Keith M Vogt
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
Gustavo Vazquez
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults
University of Colorado, Denver
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
University of Pennsylvania
Ketamine Assisted Psychotherapy for Treating Comorbid Chronic Pain and PTSD
Dr. Yuliya Knyahnytska
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Salma Health, Inc.
Psilocybin for Prolonged Grief Disorder
University of Virginia
Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder
Centre for Addiction and Mental Health
Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants
University Hospital, Basel, Switzerland
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
University of Virginia
Pharmacokinetics of Didehydro-LSD (DDH-LSD) Compared With LSD
University Hospital, Basel, Switzerland
Prospective IR-led Sedation Feasibility
CAMC Health System
The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.
National and Kapodistrian University of Athens
Ketamine for Veterans With Parkinson's Disease
VA Office of Research and Development
MDMA-Assisted Therapy for Mental Healthcare Providers
Rachel Yehuda
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
Johns Hopkins University
Ketamine for Opioid Use Disorder
University of Maryland, Baltimore
Psilocybin Microdose for Psychological and Existential Distress in Palliative Care (PSYCHED-PAL-RCT)
Bruyère Health Research Institute.
LSD Treatment for Persons With Alcohol Use Disorder
Felix Mueller
Pilot Study of RR-HNK in OCD
Carolyn Rodriguez
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
The Ketamine Research Foundation
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
Janssen Research & Development, LLC
RCT of Psilocybin-assisted CBT for Depression
University of California, Los Angeles
Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer
Alan Davis
Psilocybin on Brain Mechanisms of Motivation in OUD
University of Pennsylvania
Psilocybin for Opioid Use Disorder (OUD)
NYU Langone Health
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
Cybin IRL Limited
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.